Picture of GemVax & KAEL Co logo

082270 GemVax & KAEL Co Balance Sheet

0.000.00%
kr flag iconLast trade - 00:00
TechnologyAdventurousSmall CapSucker Stock

Annual balance sheet for GemVax & KAEL Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

R2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments69,59654,47231,79839,11217,000
Net Total Accounts Receivable
Net Total Receivables32,5877,5517,0084,1064,993
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets110,81668,49252,61260,13633,731
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment12,49721,19926,34332,48037,498
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets160,494158,800172,338151,143135,153
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities63,88720,66516,14015,82425,989
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities68,22623,59418,35216,79227,135
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity92,268135,206153,986134,351108,019
Total Liabilities & Shareholders' Equity160,494158,800172,338151,143135,153
Total Common Shares Outstanding